Asset Details
Do you wish to reserve the book?
Commutability Limitations Influence Quality Control Results with Different Reagent Lots
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Commutability Limitations Influence Quality Control Results with Different Reagent Lots
Do you wish to request the book?
Commutability Limitations Influence Quality Control Results with Different Reagent Lots
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Commutability Limitations Influence Quality Control Results with Different Reagent Lots
2011
Overview
Good laboratory practice includes verifying that each new lot of reagents is suitable for use before it is put into service. Noncommutability of quality control (QC) samples with clinical patient samples may preclude their use to verify consistency of results for patient samples between different reagent lots.
Patient sample results and QC data were obtained from reagent lot change verification records for 18 QC materials, 661 reagent lot changes, 1483 reagent lot change-QC events, 82 analytes, and 7 instrument platforms. The significance of between-lot differences in the results for QC samples compared with those for patient samples was assessed by a modified 2-sample t test adjusted for heterogeneity of QC and patient sample measurement variances.
Overall, 40.9% of reagent lot change-QC events had a significant difference (P < 0.05) between results for QC samples compared with results for patient samples between 2 reagent lots. For QC results with differences <1.0 SD interval (83.1% of total), 37.7% were significantly different from the changes observed for patient samples. For QC results with differences ≥1.0 SD interval (16.9% of total), 57.0% were significantly different from those for patient samples.
Occurrence of noncommutable results for QC materials was frequent enough that the QC results could not be used to verify consistency of results for patient samples when changing lots of reagents.
Publisher
American Association for Clinical Chemistry,Oxford University Press
Subject
Analytical, structural and metabolic biochemistry
/ Biological and medical sciences
/ Clinical Chemistry Tests - standards
/ Clinical Chemistry Tests - statistics & numerical data
/ Data Interpretation, Statistical
/ Fundamental and applied biological sciences. Psychology
/ Humans
/ Indicators and Reagents - standards
/ Investigative techniques, diagnostic techniques (general aspects)
/ Reagent Kits, Diagnostic - standards
/ Reagents
/ Studies
